http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8426140-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f81c6fa05269fed8e8665a8e72778ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_946ce06d01f24475c5c8cd65a858c184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_154edb96472ea22981f3f59c0d6f1895 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f42f2d8f48dc4dd61df4af47f38cebd2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2008-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0f6ddee4b561cdfd7593157f484456 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04cc8cd6cc520c4f7efcf7ff3277255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca944edd27462a99895da156d7d5e490 |
publicationDate | 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-8426140-B2 |
titleOfInvention | Method of assessing colorectal cancer status in an individual |
abstract | The invention relates to a method of screening a patient to identify and quantify risk of colorectal cancer, and thereby identify patients suitable for further invasive investigation such as a colonoscopy. The method employs auto-antibodies that are shown to correlate with colorectal cancer risk method and involves of assaying a biological sample from the individual for a combination of a plurality of biomarkers selected from SEQUENCE ID NO's: 1 to 12, where the combination of biomarkers is chosen such that detection of all biomarkers in the patient correlates to at least a 50% risk of the patient being positive for colorectal cancer. Detection of all of the combination of biomarkers indicates that the patient should undergo a colonoscopy. Kits for performing the method of the invention are also provided. |
priorityDate | 2007-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.